Gilead Sciences, Inc. financial data

Symbol
GILD on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
333 Lakeside Dr, Foster City, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 120 % -8.82%
Quick Ratio 13.8 % -5.28%
Return On Equity 2.32 % -91.3%
Return On Assets 0.8 % -91.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.25B shares -0.12%
Common Stock, Shares, Outstanding 1.25B shares -0.16%
Entity Public Float 67B USD +19.9%
Common Stock, Value, Issued 1M USD 0%
Weighted Average Number of Shares Outstanding, Basic 1.25B shares -0.08%
Weighted Average Number of Shares Outstanding, Diluted 1.25B shares -1.11%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 27.5B USD +1.51%
Costs and Expenses 25.9B USD +42.1%
Operating Income (Loss) 1.58B USD -82.1%
Nonoperating Income (Expense) 463M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.07B USD -85.2%
Income Tax Expense (Benefit) 616M USD -64.4%
Net Income (Loss) Attributable to Parent 485M USD -91.3%
Earnings Per Share, Basic 0.39 USD/shares -91.2%
Earnings Per Share, Diluted 0.36 USD/shares -91.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.41B USD +1.39%
Marketable Securities, Current 0 USD -100%
Accounts Receivable, after Allowance for Credit Loss, Current 4.67B USD +12.2%
Inventory, Net 1.85B USD +17.6%
Assets, Current 14B USD +4.35%
Property, Plant and Equipment, Net 5.32B USD -2.88%
Operating Lease, Right-of-Use Asset 581M USD +15.1%
Intangible Assets, Net (Excluding Goodwill) 23.4B USD -17.4%
Goodwill 8.31B USD 0%
Other Assets, Noncurrent 5.19B USD +4.77%
Assets 56.3B USD -9.03%
Accounts Payable, Current 622M USD -0.8%
Employee-related Liabilities, Current 755M USD +6.79%
Accrued Liabilities, Current 3.87B USD +2.22%
Liabilities, Current 13B USD +23.6%
Accrued Income Taxes, Noncurrent 1.97B USD -47.9%
Deferred Income Tax Liabilities, Net 933M USD -61.1%
Operating Lease, Liability, Noncurrent 546M USD +16.9%
Other Liabilities, Noncurrent 1.4B USD +9.24%
Accumulated Other Comprehensive Income (Loss), Net of Tax 69M USD
Retained Earnings (Accumulated Deficit) 10.7B USD -30%
Stockholders' Equity Attributable to Parent 17.5B USD -16.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 17.5B USD -16.6%
Liabilities and Equity 56.3B USD -9.03%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.22B USD +27.2%
Net Cash Provided by (Used in) Financing Activities -1.36B USD +3.2%
Net Cash Provided by (Used in) Investing Activities -2.21B USD -167%
Common Stock, Shares Authorized 5.6B shares 0%
Common Stock, Shares, Issued 1.25B shares -0.16%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.37B USD -187%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.72B USD -4.42%
Interest Paid, Excluding Capitalized Interest, Operating Activities 891M USD -1.76%
Deferred Tax Assets, Valuation Allowance 663M USD +10.7%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 6.21B USD +17.4%
Operating Lease, Liability 671M USD +16.1%
Depreciation 94M USD 0%
Payments to Acquire Property, Plant, and Equipment 105M USD -3.67%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 573M USD -89.6%
Lessee, Operating Lease, Liability, to be Paid 763M USD +17.2%
Property, Plant and Equipment, Gross 7.77B USD +1.37%
Operating Lease, Liability, Current 125M USD +12.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 123M USD +10.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 143M USD +22.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Deferred Income Tax Expense (Benefit) -723M USD -139%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 92M USD +26%
Lessee, Operating Lease, Liability, to be Paid, Year Three 95M USD +20.3%
Deferred Tax Assets, Operating Loss Carryforwards 417M USD -3.02%
Deferred Federal Income Tax Expense (Benefit) -1.13B USD +25%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 1.96B USD +0.15%
Lessee, Operating Lease, Liability, to be Paid, Year Four 76M USD +35.7%
Operating Lease, Payments 88M USD -10.2%
Additional Paid in Capital 6.81B USD +17.6%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 80M USD +150%
Current Federal Tax Expense (Benefit) 1.78B USD -29.9%
Amortization of Intangible Assets 2.3B USD +27.8%
Deferred Tax Assets, Net of Valuation Allowance 5.55B USD +18.3%
Share-based Payment Arrangement, Expense 796M USD +23.4%
Deferred State and Local Income Tax Expense (Benefit) 170M USD
Interest Expense 968M USD +4.42%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%